Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/1999
03/18/1999WO1999012947A1 6,9-bridged erythromycin derivatives
03/18/1999WO1999012944A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
03/18/1999WO1999012936A1 Furopyrrolidine derivatives and their use as serine protease inhibitors
03/18/1999WO1999012932A1 Method of inhibiting serine protease enzymes
03/18/1999WO1999012928A1 3-(iodophenoxymethyl) carbapenem antibacterials
03/18/1999WO1999012927A1 Purine acyclonucleosides as antiviral agents
03/18/1999WO1999012919A1 Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors
03/18/1999WO1999012565A1 Vaccines
03/18/1999WO1999012563A2 Mucosal cytotoxic t lymphocyte responses
03/18/1999WO1999012557A1 Novel prokaryotic polynucleotides, polypeptides and their uses
03/18/1999WO1999012554A1 Chemical supplementation of bone
03/18/1999WO1999012552A1 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
03/18/1999WO1999012542A1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
03/18/1999WO1999012541A1 Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces
03/18/1999WO1999012523A1 Modulation of drug loading in multivesicular liposomes
03/18/1999WO1999012521A1 New foam-forming pharmaceutical composition
03/18/1999WO1999012520A1 Compositions adapted for prolonged residence in the nasal pharynx
03/18/1999WO1998056901A3 Live attenuated vaccines
03/18/1999WO1998044103A3 Protein for inhibiting apoptosis
03/18/1999DE19740571C1 Antigen-specific stimulation of T cells
03/18/1999CA2303486A1 Stabilization of helicobacter urease
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303443A1 Compositions adapted for prolonged residence in the nasal pharynx
03/18/1999CA2303422A1 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999CA2303410A1 Mucosal cytotoxic t lymphocyte responses
03/18/1999CA2303396A1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999CA2303347A1 Chemical supplementation of bone
03/18/1999CA2302710A1 New foam-forming pharmaceutical composition
03/18/1999CA2302687A1 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
03/18/1999CA2302637A1 Vaccine compositions comprising an oil/water emulsion with saponin and sterol
03/18/1999CA2302630A1 Purine acyclonucleosides as antiviral agents
03/18/1999CA2302470A1 Synthetic divalent slex containing polylactosamines and methods for use
03/18/1999CA2302009A1 3-(iodophenoxymethyl) carbapenem antibacterials
03/18/1999CA2301643A1 6,9-bridged erythromycin derivatives
03/18/1999CA2244325A1 Novel amps
03/18/1999CA2244323A1 Novel gapdh
03/18/1999CA2244241A1 Novel phoh
03/17/1999EP0902087A2 Histidine kinase
03/17/1999EP0902086A1 Tuberculosis vaccine
03/17/1999EP0902018A2 2-(Arylphenyl)amino-imidazoline derivatives
03/17/1999EP0901530A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
03/17/1999EP0901493A1 Process for the preparation of an indacene compound
03/17/1999EP0901488A1 2,4-diaminopyrimidine derivatives
03/17/1999EP0901482A1 Benzofuran carboxamides and their therapeutic use
03/17/1999EP0901379A2 Type-2 chemokine binding proteins and methods of use therefor
03/17/1999EP0901375A1 Dhea combination therapy
03/17/1999EP0901370A1 Stimulation of immune response with low doses of il-2
03/17/1999EP0901367A1 Use of nitrogen-containing complexing agents for deodorization and antimicrobial treatment of the skin and textile fibre materials
03/17/1999EP0593562B1 Topical composition containing penciclovir
03/17/1999CN1211254A Fused pyrrolo (2,3-C) carbazole-6-ones which potentiate activity of gamma interferon
03/17/1999CN1211251A 1,4-dihydropyridine compounds as bradykinin antagonists
03/17/1999CN1211193A Contraceptive release systems with antibacterial and/or antiviral effect
03/17/1999CN1211192A Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
03/17/1999CN1211184A Use of leukotriene B4 or its analogues as antiviral and antineoplastic agents
03/17/1999CN1211180A Method of treatment with compounds having RAG 'alpha' receptor specific or selective activity
03/17/1999CN1211177A Compositions containing an antifungal and a sulfur compound
03/17/1999CN1042536C Preparation of cephalosporin antibiotic using synisomer of thiazolyl intermediate cis-isomer
03/17/1999CA2244330A1 Novel histidine kinase
03/16/1999US5883239 aroA
03/16/1999US5883236 Process for N-desmethylating erythromycins and derivatives thereof
03/16/1999US5883225 Polypeptides and sequence
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883114 Indolocarbazole imides and the use thereof
03/16/1999US5883089 Bactericides and antibiotics
03/16/1999US5883074 Potentiators of antibacterial agents
03/16/1999US5882912 Retrovirus isolated from humans
03/16/1999US5882898 Cells and vectors with polynucleotides
03/16/1999US5882897 yitJ
03/16/1999US5882896 M protein
03/16/1999US5882892 Polypeptides and dna(rna) encoding and screening for bactericides
03/16/1999US5882891 Polynucleotide segments
03/16/1999US5882889 Response regulator in a two component signal transduction system
03/16/1999US5882885 Polypeptides and polynucleotides
03/16/1999US5882651 Attenuated respiratory syncytial virus vaccine compositions
03/16/1999US5882650 Influenza a virus ns1 protein, or a t cell epitope thereof, is administered to the individual in an amount sufficient to stimulate the virus protective response
03/16/1999US5882649 Presentation of antigens to the mucosal immune system.
03/16/1999US5882648 Methods of disease inhibition using acid polysaccharides extracted from nutshells
03/16/1999US5882647 Aquatic animal treatment method and composition containing cajeput oil
03/16/1999US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae.
03/16/1999CA2244232A1 Novel def
03/16/1999CA2168962C Novel substituted propane-2-ol derivatives
03/16/1999CA2168248C Antifungal nail solution
03/16/1999CA2090186C Method of treatment of hiv-seropositive individuals with dietary whey proteins
03/16/1999CA2086831C Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
03/16/1999CA2081891C Quinolizinone type compounds
03/16/1999CA2019463C Antibiotics plusbacin
03/16/1999CA1340447C Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them
03/16/1999CA1340431C Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
03/11/1999WO1999011808A1 Rna respiratory syncytial virus vaccines
03/11/1999WO1999011782A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
03/11/1999WO1999011753A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS
03/11/1999WO1999011666A1 N-terminal modifications of rantes and methods of use
03/11/1999WO1999011651A2 3-descladinose 6-o-substituded erythromycin derivatives
03/11/1999WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/11/1999WO1999011646A1 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
03/11/1999WO1999011642A1 Aminometyl oxooxazolidinyl benzene derivatives
03/11/1999WO1999011635A1 5,5-disubstituted-1,5-dihydro-4,1-benzoxazepin-2(3h)-ones useful as hiv reverse transcriptase inhibitors
03/11/1999WO1999011293A1 50 human secreted proteins
03/11/1999WO1999011286A1 Vaginal suppository vaccine for urogenital infections
03/11/1999WO1999011285A1 Composition to protect a mammal against bartonella henselae infection
1 ... 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 ... 1798